|
 Biocon Biologics, subsidiary of Biocon has once again been recognized as an Asia IP Elite for 2024 by IAM (Intellectual Asset Management), the world's leading intellectual property (IP) publication. This is the eighth consecutive year for Biocon and subsequently its subsidiary Biocon Biologics to make it to this prestigious list.
The accolade is awarded to a select group of Asia-based organisations that have demonstrated exceptional IP value creation and are considered leaders in the region. In 2016, Biocon became the first and only Indian pharmaceutical company to be featured on the prestigious ASIA IP ELITE list for its robust IP management and consistent IP value creation. Biocon Biologics is among the two pharmaceutical companies from India in the 93 companies featuring on the Asia IP Elite 2024 list.
Shreehas Tambe, CEO & managing director, Biocon Biologics, said: “Our dedicated team continues to place IP at the core of our business, driving value creation and advancing healthcare solutions for millions of patients globally.”
Biocon Biologics is leveraging its robust in-house IP strategy and capabilities to enable early entry of biosimilar products to meet patients’ needs for affordable therapy in global markets. Each year, the IAM editorial team conducts an extensive research process, incorporating both quantitative and qualitative analyses, to highlight an exclusive group of leading corporations and research institutions as inductees into the Asia IP Elite.
Each member of the Asia IP Elite showcases excellence in IP value creation and meets the criteria of placing IP strategy at the centre of its business. It obtains significant and ongoing value from intellectual property as a direct result of the strategies it employs.
It has a senior management that understands the operational and strategic importance of intellectual property. It is constantly reappraising and improving its IP strategy in order to take advantage of market developments. This year, 93 entities from India, China, Japan, South Korea, Malaysia, Thailand, Taiwan, Australia, New Zealand, and Singapore featured on the Asia IP Elite 2024 list.
|